This invention relates to an anti-dementia agent which uses a BEC 1 potassium channel inhibitor as the active ingredient.
It was proved that the BEC 1 potassium channel inhibitor has an action to improve learning disorder and is useful as a preventive or therapeutic agent for diseases, preferably dementia, in which the BEC 1 potassium channel is considered to be concerned.
Illustratively, it was confirmed by an in vivo test that the BEC 1 potassium channel inhibitor has an action to improve learning disorder.
Also, it was found that a compound having 2,4,6-triamino-1,3,5-triazine has a BEC 1 potassium channel inhibitory action.
本发明涉及一种以B
EC 1
钾离子通道
抑制剂作为活性成分的抗痴呆剂。已经证明,B
EC 1
钾离子通道
抑制剂具有改善学习障碍的作用,并且作为预防或治疗剂是有用的,尤其是对于B
EC 1
钾离子通道与之相关的疾病,如痴呆症。例如,通过体内试验证实,B
EC 1
钾离子通道
抑制剂具有改善学习障碍的作用。此外,还发现具有2,4,6-三
氨基-
1,3,5-三嗪的化合物具有B
EC 1
钾离子通道抑制作用。